<div id="readability-page-1"><div><p>Vcanbio Cell &amp; Gene Engineering Corp., Ltd reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 1,092.46 million compared to CNY 1,205.9 million a year ago. Net income was CNY 107.91 million compared to CNY 133.51 million a year ago.</p><p>Basic earnings per share from continuing operations was CNY 0.24 compared to CNY 0.29 a year ago. Diluted earnings per share from continuing operations was CNY 0.24 compared to CNY 0.29 a year ago.</p></div></div>

中源協和

<p>中源協和（Vcanbio Cell & Gene Engineering Corp., Ltd）公佈了截至 2025 年 9 月 30 日的九個月財報。銷售額從去年同期的 12.059 億元人民幣下降至 10.9246 億元人民幣。淨收入從 1.3351 億元人民幣降至 1.0791 億元人民幣。持續經營業務的基本和稀釋每股收益均為 0.24 元人民幣，較去年同期的 0.29 元人民幣下降</p>

中源協和細胞基因工程股份有限公司公佈了截至2025年9月30日的九個月財務業績